Niklason Laura E
SEC insider (Form 3/4/5 filer). CIK 0001878075. President, CEO and Director at Humacyte, Inc. (HUMA). 15 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in DURHAM, NC.
Companies Niklason Laura E has filed insider reports for
- Humacyte, Inc. (HUMA): Director, Officer, President, CEO and Director
Niklason Laura E
CIK: 0001878075
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Humacyte, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jun 11, 2026HUMA
Humacyte, Inc.
AwardIndirectStock Options (right to buy)
80K shares- - Nov 16, 2025HUMA
Humacyte, Inc.
AwardDirectStock Options (right to buy)
311.1K shares- - Aug 20, 2025HUMA
Humacyte, Inc.
SaleIndirect591.7K shares at avg. $1.58$935K - Aug 19, 2025HUMA
Humacyte, Inc.
SaleIndirect1.1M shares at avg. $1.63$1.8M - Aug 18, 2025HUMA
Humacyte, Inc.
SaleIndirect549.4K shares at avg. $1.83$1.0M - Jun 12, 2025HUMA
Humacyte, Inc.
AwardIndirectStock Options (right to buy)
0 shares- - Jan 21, 2025HUMA
Humacyte, Inc.
AwardDirectStock Options (right to buy)
1.1M shares- - Dec 19, 2024HUMA
Humacyte, Inc.
AwardDirectStock Options (right to buy)
525 shares- - Nov 20, 2024HUMA
Humacyte, Inc.
SaleIndirect261.4K shares at avg. $4.40$1.2M - Nov 19, 2024HUMA
Humacyte, Inc.
PurchaseDirect1.8K shares at avg. $4.44$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | HUMA Humacyte, Inc. | Award Stock Options (right to buy) | 80,000 | - | - | Indirect |
| Nov 16, 2025 | HUMA Humacyte, Inc. | Award Stock Options (right to buy) | 311,100 | - | - | Direct |
| Aug 20, 2025 | HUMA Humacyte, Inc. | Sale | 591,685 | $1.58 | $934,862 | Indirect |
| Aug 19, 2025 | HUMA Humacyte, Inc. | Sale | 1,100,000 | $1.63 | $1,793,000 | Indirect |
| Aug 18, 2025 | HUMA Humacyte, Inc. | Sale | 549,360 | $1.83 | $1,005,329 | Indirect |
| Jun 12, 2025 | HUMA Humacyte, Inc. | Award Stock Options (right to buy) | 0 | - | - | Indirect |
| Jan 21, 2025 | HUMA Humacyte, Inc. | Award Stock Options (right to buy) | 1,130,311 | - | - | Direct |
| Dec 19, 2024 | HUMA Humacyte, Inc. | Award Stock Options (right to buy) | 525 | - | - | Direct |
| Nov 20, 2024 | HUMA Humacyte, Inc. | Sale | 261,369 | $4.40 | $1,150,024 | Indirect |
| Nov 19, 2024 | HUMA Humacyte, Inc. | Purchase | 1,797 | $4.44 | $7,979 | Direct |
1-10 of 15 transactions